用规范建模和多中心分子神经影像研究精神分裂症和首发精神病中的多巴胺能异常
该研究将规范建模应用于两种靶向多巴胺系统的PET示踪剂([11C]-(+)-PHNO和[18F]FDOPA),在健康对照参考队列上建立模型,并用于不同疾病阶段和治疗结局的独立精神病患者队列。结果显示精神病患者极端偏差程度较对照高约3倍,但模式异质,极端偏差拓扑重叠最大20%;纹状体[18F]FDOPA信号参照规范分布可预测治疗反应(纹状体AUC ROC:0.77-0.83)。
要点
- 精神病患者极端偏差程度约为对照的3倍,但极端偏差拓扑重叠最大仅20%。
- 纹状体[18F]FDOPA信号参照规范分布可预测治疗反应,纹状体AUC ROC为0.77-0.83。
- 规范建模经适当协调后可有效应用于分子神经影像,有助于理解患者异质性。
核心结论
- 规范建模经适当协调后可有效应用于分子神经影像,有助于揭示疾病机制并推进精准医学。
- 该方法有助于理解患者人群的异质性,并可提高病例对照研究中的成本效率。
研究设计与样本
- 研究应用规范建模,对两种靶向多巴胺系统的PET示踪剂([11C]-(+)-PHNO和[18F]FDOPA)在健康对照参考队列上建立模型。
- 所建模型随后应用于不同疾病阶段和治疗结局的独立精神病患者队列。
主要发现
- 精神病患者表现出的极端偏差程度较对照高约3倍。
- 极端偏差模式呈异质性,极端偏差拓扑重叠最大为20%。
- 纹状体[18F]FDOPA信号参照规范分布时可预测治疗反应,纹状体AUC ROC为0.77-0.83。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Molecular neuroimaging techniques, like PET and SPECT, offer invaluable insights into the brain's in-vivo biology and its dysfunction in neuropsychiatric patients. However, the transition of molecular neuroimaging into diagnostics and precision medicine has been limited to a few clinical applications, hindered by issues like practical feasibility, high costs, and high between-subject heterogeneity of neuroimaging measures. In this study, we explore the use of normative modelling (NM) to identify individual patient alterations by describing the physiological variability of molecular functions. NM potentially addresses challenges such as small sample sizes and diverse acquisition protocols typical of molecular neuroimaging studies. We applied NM to two PET radiotracers targeting the dopaminergic system ([11C]-(+)-PHNO and [18F]FDOPA) to create a reference-cohort model of healthy controls. The models were subsequently utilized on different independent cohorts of patients with psychosis in different disease stages and treatment outcomes. Our results showed that patients with psychosis exhibited a higher degree of extreme deviations (~3-fold increase) than controls, although this pattern was heterogeneous, with minimal overlap of extreme deviations topology (max 20%). We also confirmed that striatal [18F]FDOPA signal, when referenced to a normative distribution, can predict treatment response (striatal AUC ROC: 0.77-0.83). In conclusion, our results indicate that normative modelling can be effectively applied to molecular neuroimaging after proper harmonization, enabling insights into disease mechanisms and advancing precision medicine. In addition, the method is valuable in understanding the heterogeneity of patient populations and can contribute to maximising cost efficiency in studies aimed at comparing cases and controls.
引用
- Giacomel A, Martins D, Nordio G, et al. Investigating dopaminergic abnormalities in schizophrenia and first-episode psychosis with normative modelling and multisite molecular neuroimaging. Mol Psychiatry. 2025. PMID: 40021831. doi:10.1038/s41380-025-02938-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。